Synlait Milk (ASX:SM1) share price on watch after earnings halve due to a2 Milk (ASX:A2M) update

The Synlait Milk Ltd (ASX:SM1) share price could be hammered on Monday after halving its FY 2021 guidance due to weak demand from A2 Milk Company Ltd (ASX:A2M)…

| More on:
Young man looking afraid representing ASX shares investor scared of market crash

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Synlait Milk Ltd (ASX: SM1) share price will be on watch today after it released an update on its guidance.

This follows a disappointing update by its largest customer, A2 Milk Company Ltd (ASX: A2M), on Friday.

That update revealed that A2 Milk Company has experienced a more significant and protracted disruption in the daigou channel than expected. As a result, it downgraded its sales and earnings guidance materially for FY 2021.

What did Synlait announce?

This morning the dairy processor updated its FY 2021 guidance to reflect a revised demand forecast received from the infant formula company following its guidance update.

According to the release, the updated forecast from a2 Milk Company has resulted in Synlait forecasting total consumer-packaged infant formula volumes to be approximately 35% lower than FY 2020.

As a result of this change, based on initial estimates and currently available information, management expects its FY 2021 net profit after tax to be approximately half that of its FY 2020 profit result.

The company intends to provide investors with a further update on its FY 2021 profit expectations with its half year results in March.

What now?

The dairy processor's board and management team revealed that they are continuing to actively pursue opportunities to mitigate the impact of this development. This includes focusing on the execution of its diversification strategy, asset optimisation, and prudently managing costs.

It also advised that there has been no disruption to manufacturing or demand for Synlait's ingredient, lactoferrin, or consumer-goods businesses, and remains confident that it can deliver on its medium to long term objectives.

However, the company warned that its guidance remains subject to the ongoing effects of COVID-19, with consumer behaviour, channel dynamics, and supply chain disruptions all subject to change.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two colleagues at work looking at a tablet and smiling at a rising share price.
Share Gainers

Why Generation Development, Orica, Pro Medicus, and Zip shares are storming higher today

These shares are having a strong session on Thursday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ANZ, Brainchip, Light & Wonder, and Pilbara Minerals shares are falling today

These shares are tumbling on Thursday. But why?

Read more »

A picture of the US Federal Reserve podium for making media announcements.
Share Market News

Why the Fed just left interest rates on hold and what ASX investors can expect next

With the Fed keeping interest rates on hold, when can ASX investors expect the central bank’s next cut?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 114% in a year, why is the Pro Medicus share price leaping higher again on Thursday?

Pro Medicus shares are back in form today and leaping ahead. Here’s why.

Read more »

A railway worker walks along the train tracks in a visi vest and speaking into a walkie talkie.
Share Market News

Are Aurizon shares a buy, hold or sell based on Macquarie's report?

Here’s what this broker has to say about this Industrials stock

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker puts buy rating on Zip shares

Big returns could be on offer for investors according to its analysts.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Thursday

A positive session is expected for Aussie investors today. Here's what is happening.

Read more »

Man standing on rock next to turquoise salt lagoon.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 finally had a green session this hump day.

Read more »